跳转至内容
Merck
所有图片(1)

Key Documents

G004479

HPLC Analysis of Sibutramine Enantiomers on Astec® CHIROBIOTIC® V

application for HPLC

登录查看公司和协议定价


About This Item

技術

HPLC: suitable

測試參數

column: CHIROBIOTIC V, 25 cm x 4.6 mm I.D., 5 μm particles (11024AST)
mobile phase: 15 mM ammonium formate in methanol
flow rate: 1 mL/min
column temp.: 25 °C
detector: UV, 230 nm
injection: 5 μL
sample: 1 mg/mL in methanol

適合性

application for HPLC

應用

pharmaceutical (small molecule)

分析報告

Sibutramine, one of a few drugs approved for long-term treatment of obesity, is a chiral compound. The (R) enantiomer has the desired effect of reducing body weight and food intake, but the (S) enantiomer has the opposite effect: A perfect example of why chiral HPLC is important to pharmaceutical and clinical analysts. Astec® CHIROBIOTIC® V successfully separates sibutramine enantiomers, using a simple, MS-friendly mobile phase.

法律資訊

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC

分析物

说明

    Sibutramine hydrochloride monohydrate, ≥98% (HPLC), solid

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门